
Dr. Bergendahl is a trained chemist/biochemist and received his PhD in Biology 2003 from the Phillips University in Marburg, Germany. His thesis work was done with Prof. Richard Burgess at the University of Wisconsin in Madison, USA, where he later joined the lab of...
Dr. Berthold Bödeker (57) is Chief Scientist and heading pilot plants and cell culture at the CMC unit of Global Drug Discovery-Biological Development of Bayer Schering Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical...
Gang Chen has been Senior Director, Cell Technologies at Regeneron Pharmaceuticals, Inc. since Jan 2010. Gang Chen joined Regeneron in 1999 and has been working in the field of CHO cell line engineering and antibody technology ever since. Gang’s current responsibility...
Working in Novimmune (Geneva) since 2009, current position: Head of upstream processing, responsible for mammalian cell culture development for the supply of pre-clinical and clinical material, from cell line engineering to production, implementation of disposable...
I did my PhD thesis at University of Basel in the Department of Molecular Pharmacy, and then moved to Basel University Hospital for a post-doctoral training in Immunonephrology. Since 2006 I am a lab head at Novartis Biotechnology Development, i.e. Integrated...
Christel Fenge studied biochemistry at Leibniz University Hannover, and afterwards earned her doctorate at the Institut für Technische Chemie. After having held positions in the areas of both research & development and product management at B. Braun Biotech...
Dr. Goldsborough joined BD through the acquisition of Atto Biosciences in 2004. She currently is the Director of R&D for the BD Advanced Bioprocessing (AB) business where she is responsible for World Wide new product development, tech transfer and customer support...
Hansjörg Hauser is Head of the Division Molecular Biotechnology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig/Germany. He graduated at the University of Stuttgart-Hohenheim and received a Ph.D. in Biology at the University of Konstanz in...
Robert holds the position of a manager in Pharma Biotech Development Fermentation at Roche Penzberg. He is responsible for animal cell culture development for the supply of clinical material in various disease areas. Moreover, he is involved in strategic initiatives to ...
Dr. Sasa Stojkovic (36) is heading the bioprocess pilot department at the Sandoz Biopharmaceuticals Business Unit at Lek Pharmaceuticals in Menges, Slovenia, which is responsible for the bioprocess development, scale up and process transfer to clinical material...
Head of Operational Excellence for Bayer HealthCare’s Product Supply-Biotech and North America Cluster. “Hands-on Operational Excellence Practitioner with strong people and change management skills that has successfully implemented operational excellence programs in...
Hartmut Tintrup received his Ph.D. in 1998 from Frankfurt University, Germany. After finishing his Ph.D. thesis at the Max-Planck-Institute for Brain Research in Frankfurt he worked first as a Research Scientist at Artemis Pharmaceuticals GmbH, Cologne and then at...
Prof. Dr. Dr. Rolf G. Werner is Corporate Senior Vice President of the Corporate Division Biopharmaceuticals at Boehringer Ingelheim GmbH, Germany. He received his Ph.D. degree at University of Tuebingen and joined Boehringer Ingelheim in 1973 as Head of Antibiotic...
Register for Cell Culture World Congress 2011 »
Download the brochure »
50% discount for Academic and small/early stage biotechEmail us today for more information › |
World Cell Culture Congress Europe is a multi-faceted event
|
You may also like to attend:
See more › |
We run training courses on:See more › |